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Lipid droplets: Proteins floating on a pool of fat
Deborah A. Brown
Proteins on the surface of lipid storage droplets are
crucial to droplet structure and function, but are poorly
understood. Recent reports reveal a function for
perilipins, major lipid droplet proteins in adipocytes,
and show that caveolin proteins can accumulate on lipid
droplets. 
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Adipocytes and certain plant seeds contain large, well-devel-
oped lipid droplets that serve as storage depots for neutral
lipids such as triacylglycerol and sterol esters. Droplets con-
taining more modest amounts of neutral lipids are wide-
spread among eukaryotic cells. Nevertheless we are just
starting to understand the structure and dynamics of these
ubiquitous structures [1,2]. Lipid droplets are believed to
form by coalescence of neutral lipids, which are synthesized
in the endoplasmic reticulum (ER), into discs in the interior
of the bilayer. The discs enlarge into spheres and eventu-
ally bud from the ER into the cytoplasm, becoming sur-
rounded by a phospholipid monolayer derived from the ER. 
Although the interior of lipid droplets consists entirely of
neutral lipids, a number of proteins are present on the
droplet surface. These proteins undoubtedly play key
roles in lipid droplet structure and function, but very little
is known about them. Recent studies [3–6] in two areas
extend our understanding of lipid droplet proteins.
Brasaemle et al. [3] have discovered a function for per-
ilipin, the major lipid droplet protein in adipocytes. And
three recent papers [4–6] show that caveolin proteins, gen-
erally restricted to cell-surface caveolae and to the Golgi
apparatus, can accumulate in lipid droplets. The physio-
logical significance of this finding is not yet clear, but this
surprising new localization may provide clues to how pro-
teins are targeted to lipid droplets.
Perilipin is the major lipid-droplet protein in adipocytes,
where it makes up 0.25 to 0.5% of total cell protein [1].
(Perilipin A, B, and C result from alternative splicing of a
single perilipin gene.) Perilipin appears to be restricted to
adipocytes and steroidogenic cells, which are also special-
ized for lipid storage. These properties suggest that per-
ilipin plays an important role in lipid droplet dynamics, but
its functions have not been clear. Brasaemle et al. [3] have
now expressed perilipin A — the predominant adipocyte
isoform — in 3T3-L1 pre-adipocytes, which normally lack
the protein. As a result, lipid droplets acquired a perilipin
coat, became more numerous and clustered together. Tria-
cylglycerol levels were elevated 6- to 30-fold through a
reduction in the lipid hydrolysis rate; there was no signifi-
cant effect on the rate of lipid synthesis.
Despite the observed reduction in lipid hydrolysis rate,
perilipin A does not directly inhibit cellular lipases when
assayed in vitro. Instead, the authors [3] suggest that per-
ilipin A sterically blocks access of hormone-sensitive
lipase, which catalyzes the rate-limiting step in triacylglyc-
erol hydrolysis, to the droplet surface (Figure 1). Lipolysis
is stimulated in vivo by adrenaline, through the activation
of protein kinase A in response to elevated cAMP levels,
and perilipin A is a major substrate for protein kinase A.
Brasaemle et al. [3] propose the intriguing model whereby
phosphorylation of perilipin A facilitates access of
hormone-sensitive lipase to the droplet surface, thus stim-
ulating lipolysis in a hormone-dependent manner.
Although perilipin can be a major protein component of
lipid droplets — in adipocytes and steroidogenic cells —
Figure 1
Role of perilipins in adipocyte lipid droplets [3]. Lipid droplets contain a
neutral lipid core surrounded by a phospholipid monolayer. Perilipins
associate with lipid droplets and could plausibly coat the entire surface
[3]. Exogenous perilipin expression in 3T3-L1 pre-adipocytes retards
triacylglycerol hydrolysis, possibly through sterically blocking access of
hormone-sensitive lipase to the droplet surface. Proteins and lipids are
not drawn to scale.
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there are of course others. Three recent reports [4–6] now
show that caveolins can also accumulate on the surface of
lipid droplets (see also [7]). Caveolins such as caveolins-1
and 2, which are widespread in mammalian cells, and
the muscle-specific caveolin-3, form a coat that surrounds
50–100 nm flask-shaped invaginations of the plasma mem-
brane called caveolae [8,9]. Caveolae have been reported
to function in endocytosis, signal transduction, growth
control and cholesterol transport [8,9] although it is not yet
clear how these disparate roles are coordinated. Caveolins
are localized primarily at the plasma membrane, with a
smaller pool in the Golgi apparatus. 
Pol et al. [6] show that amino-terminal truncation mutants
of caveolins 1, 2 and 3 are targeted to lipid droplets. One of
these mutants, Cav-3DGV, is already known to be targeted
to the early Golgi [10]. In this new study [6], Cav-3DGV is
found in both the Golgi and lipid droplets. The Golgi pool
disappears after cycloheximide treatment, suggesting that
it is transient. In earlier work, the authors [11] showed that
Cav-3DGV has a dominant-negative effect on cholesterol
transport to the cell surface, and inhibits H-Ras signaling
by disrupting cholesterol-dependent plasma membrane
rafts. In their recent study [6], they use filipin staining to
suggest that Cav-3DGV expression redirects cholesterol from
the plasma membrane to late endosomes [6].
Fujimoto et al. [4] show that overexpressed caveolin-2
is targeted to lipid droplets. They suggest that the lipid
droplet surface may be an important site of intracellular
signaling. Consistent with this idea, mitogen-activated
protein kinase and phosphatidylinositol 3-kinase localize
to the lipid droplet surface in certain myeloid cells, which
mobilize stored lipid to generate arachidonic acid used in
eicosanoid synthesis [12,13]. 
We [5] have shown showed that Cav-KKSL — caveolin-1
with an ER retrieval sequence appended to the carboxyl
terminus — is localized to lipid droplets as well as to the
ER, and is often highly concentrated in the droplets. An
internal-deletion mutant of caveolin-1 also accumulates in
the droplets, as well as in the Golgi. Overexpressed cav-
eolin-2 shows the same localization. Finally, treating cells
with brefeldin A to block forward transport through the
secretory pathway causes endogenous caveolin to accumu-
late in the droplets. 
To unify these disparate results, we [5] propose that accu-
mulation of caveolins to unusually high levels in the ER
may be sufficient for lipid droplet targeting. This can
explain the localization patterns reported in all three papers,
if overexpressed caveolin-2 and the mutants fold poorly
and are thus transported inefficiently through the secre-
tory pathway. Caveolin-2 expressed in the absence of
caveolin-1 is known to accumulate in the Golgi apparatus
[7], possibly reflecting inefficient transport. We do not
yet know why caveolins accumulate in lipid droplets only
under unusual circumstances. It is also not yet clear whether
targeting of caveolin to lipid droplets is physiologically rel-
evant. Even before its significance is determined,
however, this novel localization may shed new light on
general mechanisms of lipid droplet targeting. 
Relatively few lipid droplet proteins are known, and very
little is known about how they are targeted to the droplets.
Structurally, lipid droplet proteins can be divided into at
least two classes. The first includes perilipins and adipocyte
differentiation-related protein — ADRP or adipophilin —
a protein that is present on lipid droplets in most mam-
malian cells [1]. Proteins in this class are translated on
free ribosomes and recruited to the droplets from the
cytosol (unpublished data cited in [1]). Lipid droplet asso-
ciation of some of these proteins, including perilipin and
hormone-sensitive lipase, is reversible, and the proteins
cycle between the cytosol and lipid droplets depending on
the nutritional status of the cell [14].
In contrast, membrane-spanning proteins do not seem to
be present in lipid droplets. This is not surprising, as the
phospholipid monolayer surrounding lipid droplets floats
on a hydrophobic core. Proteins that have a hydrophilic
domain on either side of a membrane bilayer could not
easily be accommodated in this structure. Nevertheless,
some lipid droplet proteins contain long hydrophobic amino
acid sequences that are usually diagnostic of membrane-
spanning domains. The best characterized of these are
oleosins, proteins that coat lipid droplets in certain plant
seeds and may protect droplets from coalescence during
rehydration following desiccation [2]. Caveolins, which are
co-translationally inserted into the ER in a signal recogni-
tion particle-dependent manner [15], now join oleosins as
integral lipid droplet proteins. 
Caveolins and oleosins have strikingly similar topologies:
both are comprised of two hydrophilic cytoplasmic domains
that flank a central hydrophobic domain. An attractive
model is that the hydrophobic domain penetrates into
the phospholipid monolayer, and possibly into the neutral
lipid core, while the hydrophilic domains extend into the
cytoplasm. (Caveolins are thought to have a similar dispo-
sition in membranes, where the central hydrophobic
domain is embedded in the bilayer.) This topology sug-
gests a mechanism for delivery of these proteins to lipid
droplets (Figure 2). After synthesis, they could diffuse lat-
erally between the ER proper and nascent lipid droplets
that were still contained in the membrane. In this manner,
the proteins could enter the droplets without exposing
their hydrophobic domains to the cytosol. In contrast,
transmembrane ER proteins would be excluded from the
forming droplets (Figure 2). Although this model can
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explain how caveolins and oleosins gain access to lipid
droplets, however, it does not explain how they are
specifically targeted to the droplets and become concen-
trated there.
Sequences required for lipid droplet targeting of a few pro-
teins have been identified [1,2,16]. However, no consensus
has emerged, and these sequences have not illuminated
the mechanism of targeting. Two classes of targeting mech-
anism can be imagined. Proteins could bind directly to the
lipids in the droplet surface. Alternatively, they could bind
to other droplet proteins. At least some lipid droplet pro-
teins must interact directly with lipids. This is because
lipid droplets, unlike membranes, are continuously synthe-
sized de novo. No pre-existing compartment houses pro-
teins that could serve as docking sites for new proteins.
How do proteins that interact directly with lipids distin-
guish the lipid droplet surface from the ER? The phos-
pholipid monolayer surrounding lipid droplets might be
expected to be a random sample of ER membrane, except
for the lack of transmembrane proteins. The question
applies to integral as well as peripheral proteins. If oleosins
and caveolins can diffuse freely between the ER and the
surface of forming droplets, why do they become highly
concentrated in the droplets?
Caveolins may interact directly with droplet lipids. Indeed,
if caveolins do not function in droplets, and are only mis-
targeted there under non-physiological circumstances, it
would be surprising if specific interactions between cav-
eolins and droplet proteins had evolved. It would seem
more likely that caveolins are sometimes ‘accidentally’ tar-
geted to the droplets through an affinity for the lipids
there. This affinity may reflect a physiologically relevant
association of caveolin with lipids elsewhere in the cell
that, maybe coincidentally, are present in a similar state. 
Caveolins have a high affinity for plasma membrane micro-
domains called lipid rafts [8,9]. Rafts are characterized by
the tight packing and high degree of order of their lipid
acyl chains [17]. Could the affinity of caveolins for lipid
droplets be related to their affinity for rafts? If so, it
would suggest that lipids in the lipid droplet surface are
more ordered than those in the ER. Lipid droplet-local-
ized Cav-3DGV is insoluble in cold non-ionic detergents, a
hallmark of raft-associated proteins [6]. (As a cautionary
note, however, the basis of lipid droplet detergent-insolu-
bility is not as well understood as that of bilayers.) Some
workers have found high levels of free cholesterol — a
raft-promoting lipid — in the lipid droplet surface [18],
although others have not [7].
If the lipid droplet surface exists in a different physical
state than the ER membrane, then endogenous lipid
droplet proteins, as well as caveolin, might use this prop-
erty in targeting. The chemical and physical properties of
the lipid droplet surface are not well understood. Contact
with the underlying core might affect the packing of phos-
pholipids in the monolayer. This might cause selective
recruitment of certain lipids in the ER membrane to the
surface of developing droplets. A better characterization of
the lipid droplet surface will clearly be required to under-
stand how proteins function there.
Acknowledgements
I thank Erwin London for reading the manuscript. This work was supported
by NIH grant GM 47897.
References
1. Londos C, Brasaemle DL, Schultz CJ, Segrest JP, Kimmel AR:
Perilipins, ADRP, and other proteins that associate with
intracellular neutral lipid droplets in animal cells. Semin Cell Dev
Biol 1999, 10:51-58.
2. Murphy DJ, Vance J: Mechanisms of lipid-body formation. Trends
Biochem Sci 1999, 24:109-115.
3. Brasaemle DL, Rubin B, Harten IA, Gruia-Gray J, Kimmel AR,
Londos C: Perilipin A increases triacylglycerol storage by
decreasing the rate of triacylglycerol hydrolysis. J Biol Chem
2000, 275:38486-38493.
4. Fujimoto T, Kogo H, Ishiguro K, Tauchi K, Nomura R: Caveolin-2 is
targeted to lipid droplets, a new ‘membrane domain’ in the cell.
J Cell Biol 2001, 152:1079-1086.
5. Ostermeyer AG, Paci JM, Zeng Y, Lublin DM, Munro S, Brown DA:
Accumulation of caveolin in the endoplasmic reticulum redirects
the protein to lipid storage droplets. J Cell Biol 2001,
152:1071-1078.
Figure 2
How caveolins and oleosins could enter lipid droplets. Synthesis of
neutral lipids in the ER membrane causes the membrane to bulge, as
the lipids accumulate in a disc in the center of the membrane and
drive opposite monolayers apart. The droplet will eventually pinch off
from the ER membrane into the cytoplasm, surrounded by an ER-
derived phospholipid monolayer. Transmembrane proteins should be
excluded from forming droplets, as their membrane-spanning
domains are too short to fit in the thickening bilayer. Caveolins and
oleosins, by contrast, are free to diffuse between the ER membrane
bilayer and the forming droplet, as they do not contain luminal
hydrophilic domains.
ER lumen
Transmembrane
protein
Forming
lipid
droplet
Caveolin/
oleosin
Current Biology   
6. Pol A, Luetterforst R, Lindsay M, Heino S, Ikonen E, Parton RG:
A caveolin dominant negative mutant associates with lipid bodies
and induces intracellular cholesterol imbalance. J Cell Biol 2001,
152:1057-1070.
7. van Meer G: Caveolin, cholesterol, and lipid droplets? J Cell Biol
2001, 152:F29-F34.
8. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA,
Scherer PE, Okamoto T, Lisanti MP: Caveolins, liquid-ordered
domains, and signal transduction. Mol Cell Biol 1999,
19:7289-7304.
9. Kurzchalia TV, Parton RG: Membrane microdomains and caveolae.
Curr Opin Cell Biol 1999, 11:424-431.
10. Luetterforst R, Stang E, Zorzi N, Carozzi A, Way M, Parton RG:
Molecular characterization of caveolin association with the Golgi
complex: Identification of a cis-Golgi targeting domain in the
caveolin molecule. J Cell Biol 1999, 145:1443-1460.
11. Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E,
Rolls B, Hancock JF, Parton RG: Dominant-negative caveolin
inhibits H-Ras function by disrupting cholesterol-rich plasma
membrane domains. Nat Cell Biol 1999, 1:98-105.
12. Yu W, Bozza PT, Tzizik DM, Gray JP, Cassara J, Dvorak AM,
Weller PF: Co-compartmentalization of MAP kinase and cytosolic
phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies.
Am J Pathol 1998, 152:759-769.
13. Yu W, Cassara J, Weller PF: Phosphatidylinositide 3-kinase
localizes to cytoplasmic lipid bodies in human polymorphonuclear
leukocytes ad other myeloid-derived cells. Blood 2000,
95:1078-1085.
14. Clifford GM, Londos C, Kraemer FB, Vernon RG, Yeaman SJ:
Translocation of hormone-sensitive lipase and perilipin upon
lipolytic stimulation of rat adipocytes. J Biol Chem 2000,
275:5011-5015.
15. Monier S, Parton RG, Vogel F, Behlke J, Henske A, Kurzchalia TV:
VIP21-caveolin, a membrane protein constituent of the caveolar
coat, oligomerizes in vivo and in vitro. Mol Biol Cell 1995,
6:911-927.
16. Hope RG, McLauchlan J: Sequence motifs required for lipid droplet
association and protein stability are unique to the hepatitis C virus
core protein. J Gen Virol 2000,1 81:1913-1925.
17. Brown DA, London E: Structure and function of sphingolipid- and
cholesterol-rich membrane rafts. J Biol Chem 2000,
275:17221-17224.
18. Prattes S, Hörl G, Hammer A, Blaschitz A, Graier WF, Sattler W,
Zechner R, Steyrer E: Intracellular distribution and mobilization of
unesterified cholesterol in adipocytes: triglyceride droplets are
surrounded by cholesterol-rich ER-like surface layer structures.
J Cell Sci 2000, 113:2977-2989.
Dispatch R449
